Evidence map›Paper›PMID 35027871›Full record

ArticleJournal of biomolecular techniques : JBT2021

The One Hour COVID Test: A Rapid Colorimetric Reverse-Transcription LAMP-Based COVID-19 Test Requiring Minimal Equipment.

Christopher M Monaco, Ellen Jorgensen, Sarah Ware

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomolecular techniques : JBT, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher M MonacoBioBlaze Community Bio Lab, Aanika Biosciences, Inc.
Ellen JorgensenBioBlaze Community Bio Lab, Aanika Biosciences, Inc.
Sarah WareBioBlaze Community Bio Lab, Aanika Biosciences, Inc.
Blaze Bioscience (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At this writing, over 100 million people have tested positive for Corona Virus Disease-19 (COVID-19), and the global death toll from this disease has reached nearly 3 million. Despite the many tests currently available, we have not yet achieved the testing capacity needed to limit the spread of the virus and mitigate suffering worldwide. We have developed the One Hour COVID Test to address this challenge. Our test leverages an easy-to-use, commercially available oral swab kit for sample collection paired with a novel RNA processing protocol and a simple colorimetric assay that requires minimal equipment. The test can be easily scaled via automation and takes 1 h from sample collection to result.

Indexed as

ColorimetryCOVID-19COVID-19 TestingHumansMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesProthrombin TimeRNA, ViralSARS-CoV-2Sensitivity and SpecificityRNA, ViralNAATpoint-of-careSARS-CoV-2

Identifiers

PMID35027871
PMCPMC8730513
OpenAlexW4205214326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.